Table 3.
Overview of sample size, gender ratio, the prevalence of sarcopenia, and cirrhosis severity by Child–Pugh scoring across selected studies
| Study | Sarcopenia events (N) | Sample size (N) | Male (N) | Female (N) | Prevalence of sarcopenia (%) | Male sarcopenia events (N) | Female sarcopenia events (N) | Child–Pugh A (N) | Child–Pugh B (N) | Child–Pugh C (N) |
| Iacob et al, 2022 (16) | 38 | 71 | 48 | 23 | 53.5 | Not reported | Not reported | 32 | 24 | 15 |
| Anand et al, 2022 (17) | 27 | 219 | 168 | 51 | 12.3 | 24 | 3 | Not reported | Not reported | Not reported |
| Topan et al, 2022 (18) | 115 | 201 | 127 | 294 | 57.2 | 76 | 39 | 41 | 82 | 78 |
| Zeng et al, 2022 (19) | 108 | 480 | 286 | 184 | 22.5 | 86 | 22 | 182 | 217 | 81 |
| Hanai et al, 2021 (20) | 74 | 421 | Not reported | Not reported | 17.6 | Not reported | Not reported | 303 | 97 | 21 |
| Paternostro et al, 2020 (21) | 77 | 203 | 138 | 65 | 37.9 | 62 | 15 | Not reported | Not reported | Not reported |
| Nishikawa et al, 2020 (22) | 25 | 190 | 103 | 87 | 13.1 | 12 | 13 | Not reported | Not reported | Not reported |
| Traub et al, 2020 (23) | 41 | 114 | 86 | 28 | 36.0 | 36 | 5 | 51 | 43 | 20 |
| Kim et al, 2020 (24) | 14 | 125 | Not reported | Not reported | 11.2 | Not reported | Not reported | Not reported | Not reported | Not reported |
| Salman et al, 2020 (25) | 27 | 52 | 38 | 14 | 51.9 | 18 | 9 | 52 | 0 | 0 |
| Okubo et al, 2020 (26) | 28 | 76 | 41 | 35 | 36.8 | 19 | 9 | Not reported | Not reported | Not reported |
| Saeki et al, 2019 (27) | 48 | 142 | 90 | 52 | 33.8 | 26 | 22 | 94 | 48 | 0 |
| Hanai et al, 2019 (28) | 277 | 563 | 375 | 188 | 49.2 | 221 | 56 | 377 | 135 | 51 |
| Kim et al, 2020 (29) | 36 | 334 | Not reported | Not reported | 10.8 | Not reported | Not reported | Not reported | Not reported | Not reported |
| Nishikawa et al, 2019 (30) | 29 | 152 | Not reported | Not reported | 19.1 | Not reported | Not reported | 113 | 37 | 2 |
| Montano-Loza et al, 2012 (31) | 45 | 112 | 78 | 34 | 40.2 | 39 | 6 | 12 | 66 | 34 |
| Fujita et al, 2020 (32) | 33 | 51 | 26 | 25 | 64.7 | 21 | 12 | 9 | 21 | 21 |
| Santos et al, 2019 (33) | 14 | 261 | 161 | 100 | 5.36 | Not reported | Not reported | Not reported | Not reported | Not reported |
| Carey et al, 2017 (34) | 178 | 396 | 277 | 119 | 45 | 139 | 39 | Not reported | Not reported | Not reported |
| Benmassaoud et al, 2022 (35) | 230 | 628 | 429 | 199 | 36.60 | 177 | 53 | 42 | 300 | 286 |
| Anand et al, 2021 (36) | 26 | 180 | 143 | 37 | 14.4 | 21 | 5 | 94 | 61 | 25 |
| Nakamura et al, 2022 (37) | 58 | 122 | 75 | 47 | 47.5 | Not reported | Not reported | 68 | 36 | 18 |
| Marasco et al, 2022 (38) | 82 | 159 | 128 | 31 | 51.6 | 68 | 14 | |||
| Murata et al, 2022 (39) | 40 | 151 | 95 | 56 | 26.5 | Not reported | Not reported | 117 | 28 | 6 |
| Luengpradidgun et al, 2022 (40) | 30 | 50 | 28 | 22 | 60.0 | 11 | 19 | 41 | 6 | 3 |
| Liu et al, 2022 (41) | 145 | 224 | 159 | 65 | 64.7 | 113 | 32 | Not reported | Not reported | Not reported |
| Jeong et al, 2018 (42) | 64 | 131 | 94 | 37 | 48.9 | 55 | 9 | 50 | 49 | 32 |
| Ebadi et al, 2020 (43) | 188 | 603 | 408 | 195 | 31.2 | 153 | 35 | Not reported | Not reported | Not reported |
| Kumar et al, 2019 (44) | 55 | 115 | 104 | 11 | 47.8 | 51 | 4 | 1 | 26 | 88 |
| Kappus et al, 2020 (45) | 61 | 355 | 232 | 123 | 17.2 | 57 | 4 | Not reported | Not reported | Not reported |
| Feng et al, 2020 (46) | 238 | 492 | 365 | 127 | 48.4 | 183 | 55 | 209 | 202 | 81 |
| Kang et al, 2018 (47) | 190 | 452 | 379 | 73 | 42 | 178 | 12 | 215 | 200 | 37 |
| Engelmann et al 2018 (48) | 126 | 514 | 363 | 151 | 24.50 | — | — | 112 | 235 | 167 |
| Begini et al, 2017 (49) | 37 | 92 | 27 | 65 | 40.20 | 20 | 17 | 51 | 39 | 2 |
| Meza-Junco et al, 2013 (50) | 35 | 116 | 98 | 18 | 30.20 | 30 | 5 | 62 | 38 | 16 |
| Hou et al, 2021 (51) | 100 | 274 | 144 | 130 | 36.50 | 70 | 30 | 102 | 128 | 44 |